A detailed history of Laurel Wealth Advisors, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Laurel Wealth Advisors, Inc. holds 6,121 shares of EW stock, worth $400,803. This represents 0.05% of its overall portfolio holdings.

Number of Shares
6,121
Previous 6,121 -0.0%
Holding current value
$400,803
Previous $506,000 9.68%
% of portfolio
0.05%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$86.5 - $128.27 $77,850 - $115,443
-900 Reduced 12.82%
6,121 $582,000
Q1 2022

May 13, 2022

SELL
$101.96 - $128.34 $5,301 - $6,673
-52 Reduced 0.74%
7,021 $827,000
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $165,086 - $202,815
1,552 Added 28.11%
7,073 $916,000
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $158,893 - $189,526
-1,544 Reduced 21.85%
5,521 $625,000
Q4 2020

Mar 03, 2021

BUY
$71.69 - $91.23 $10,323 - $13,137
144 Added 2.08%
7,065 $645,000
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $265,489 - $355,047
4,614 Added 200.0%
6,921 $479,000
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $5,241 - $8,100
-100 Reduced 4.15%
2,307 $435,000
Q4 2019

Feb 13, 2020

BUY
$71.7 - $82.09 $3,585 - $4,104
50 Added 2.12%
2,407 $562,000
Q3 2019

Nov 13, 2019

BUY
$61.55 - $75.43 $26,281 - $32,208
427 Added 22.12%
2,357 $518,000
Q2 2019

Aug 13, 2019

SELL
$55.74 - $64.41 $20,568 - $23,767
-369 Reduced 16.05%
1,930 $357,000
Q1 2019

May 16, 2019

BUY
$47.89 - $64.05 $23,705 - $31,704
495 Added 27.44%
2,299 $440,000
Q4 2018

Feb 13, 2019

BUY
$46.41 - $56.94 $4,641 - $5,694
100 Added 5.87%
1,804 $92,000
Q1 2018

May 16, 2018

BUY
$37.19 - $47.45 $63,371 - $80,854
1,704 New
1,704 $237,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Laurel Wealth Advisors, Inc. Portfolio

Follow Laurel Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Laurel Wealth Advisors, Inc. with notifications on news.